EA200400603A1 - Новые пептиды - аналоги гормона высвобождения гормона роста человека - Google Patents
Новые пептиды - аналоги гормона высвобождения гормона роста человекаInfo
- Publication number
- EA200400603A1 EA200400603A1 EA200400603A EA200400603A EA200400603A1 EA 200400603 A1 EA200400603 A1 EA 200400603A1 EA 200400603 A EA200400603 A EA 200400603A EA 200400603 A EA200400603 A EA 200400603A EA 200400603 A1 EA200400603 A1 EA 200400603A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- guanidine
- aminobutyric acid
- acid
- homoarginine
- leu
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 102000002265 Human Growth Hormone Human genes 0.000 title 1
- 108010000521 Human Growth Hormone Proteins 0.000 title 1
- 239000000854 Human Growth Hormone Substances 0.000 title 1
- 230000003054 hormonal effect Effects 0.000 title 1
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 abstract 6
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 abstract 4
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 abstract 2
- 102000018997 Growth Hormone Human genes 0.000 abstract 2
- 108010051696 Growth Hormone Proteins 0.000 abstract 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 239000000122 growth hormone Substances 0.000 abstract 2
- 229960003104 ornithine Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 abstract 1
- 229930028154 D-arginine Natural products 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000007515 enzymatic degradation Effects 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920000307 polymer substrate Polymers 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Новые пептиды - аналоги гормона высвобождения гормона роста, имеющие последовательность аминокислот формулы Dat-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-R-R-Val-Leu-Ala-Gln-Leu-Ser-Ala-R-R-Leu-Leu-Gln-Asp-Ile-Nle-Asp-R-NH(I), в которой Rпредставляет собой гомоаргинин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой гомоаргинин, орнитин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой гомоаргинин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой гомоаргинин, орнитин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой D-аргинин, гомоаргинин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; а также их фармацевтически приемлемые соли являются мощными и селективными стимуляторами высвобождения гормона роста и обладают высокой стойкостью к ферментному расщеплению. Новые пептиды получают с использованием способа твердофазного синтеза, включающего: введение подходящих заместителей лизина, 2,4-диаминомасляной кислоты или 2,3-диаминопропионовой кислоты на соответствующие позиции в пептидной цепи, присоединенной к полимерной подложке, снятие защиты с боковых аминогрупп и взаимодействие свободных аминогрупп с гуанидирующим агентом, удаление всех остальных защитных трет-бутилоксикарбонильных групп, а также отделение синтезированного пептида от указанной подложки с последующей его очисткой и необязательное превращение указанного пептида в фармацевтически приемлемую соль.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL350463A PL195917B1 (pl) | 2001-10-31 | 2001-10-31 | Nowe peptydy - analogi ludzkiego hormonu uwalniającego hormon wzrostu |
| PCT/PL2002/000080 WO2003037928A2 (en) | 2001-10-31 | 2002-10-30 | Analogs of human growth hormone-releasing hormone, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200400603A1 true EA200400603A1 (ru) | 2006-06-30 |
| EA007841B1 EA007841B1 (ru) | 2007-02-27 |
Family
ID=20079564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200400603A EA007841B1 (ru) | 2001-10-31 | 2002-10-30 | Новые пептиды - аналоги гормона высвобождения гормона роста человека |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7928063B2 (ru) |
| EP (1) | EP1442059B1 (ru) |
| JP (1) | JP4401170B2 (ru) |
| AT (1) | ATE353917T1 (ru) |
| AU (1) | AU2002351536A1 (ru) |
| CA (1) | CA2465667C (ru) |
| DE (1) | DE60218199T2 (ru) |
| EA (1) | EA007841B1 (ru) |
| ES (1) | ES2282494T3 (ru) |
| HU (1) | HU229220B1 (ru) |
| PL (1) | PL195917B1 (ru) |
| SI (1) | SI1442059T1 (ru) |
| UA (1) | UA79440C2 (ru) |
| WO (1) | WO2003037928A2 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060128615A1 (en) * | 2002-09-18 | 2006-06-15 | Pierrette Gaudreau | Ghrh analogues |
| WO2011153491A2 (en) | 2010-06-03 | 2011-12-08 | University Of Miami | Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
| US20130261058A1 (en) * | 2010-09-16 | 2013-10-03 | University Of Miami | Acceleration of wound healing by growth hormone releasing hormone and its agonists |
| EP2640400A4 (en) * | 2010-11-19 | 2016-01-20 | Sirna Therapeutics Inc | (POLY) AMID POLYMERS FOR THE ADMINISTRATION OF OLIGONUCLEOTIDES |
| CA2852468A1 (en) * | 2011-10-18 | 2013-04-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocyles |
| US9079974B2 (en) * | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
| US9855312B2 (en) | 2012-12-21 | 2018-01-02 | University Of Miami | GHRH agonists for the treatment of ischemic disorders |
| WO2014100816A2 (en) | 2012-12-21 | 2014-06-26 | University Of Miami | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5416073A (en) * | 1983-08-10 | 1995-05-16 | The Adminstrators Of The Tulane Educational Fund | Growth hormone-releasing peptides and method of treating animals, therewith |
| US5792747A (en) * | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
| US6072075A (en) * | 1997-05-22 | 2000-06-06 | The Regents Of The University Of California | Guanidinylation reagents |
-
2001
- 2001-10-31 PL PL350463A patent/PL195917B1/pl unknown
-
2002
- 2002-10-30 EA EA200400603A patent/EA007841B1/ru not_active IP Right Cessation
- 2002-10-30 US US10/494,218 patent/US7928063B2/en not_active Expired - Fee Related
- 2002-10-30 AU AU2002351536A patent/AU2002351536A1/en not_active Abandoned
- 2002-10-30 SI SI200230531T patent/SI1442059T1/sl unknown
- 2002-10-30 JP JP2003540209A patent/JP4401170B2/ja not_active Expired - Fee Related
- 2002-10-30 WO PCT/PL2002/000080 patent/WO2003037928A2/en not_active Ceased
- 2002-10-30 AT AT02786274T patent/ATE353917T1/de not_active IP Right Cessation
- 2002-10-30 EP EP02786274A patent/EP1442059B1/en not_active Expired - Lifetime
- 2002-10-30 HU HU0401589A patent/HU229220B1/hu not_active IP Right Cessation
- 2002-10-30 ES ES02786274T patent/ES2282494T3/es not_active Expired - Lifetime
- 2002-10-30 DE DE60218199T patent/DE60218199T2/de not_active Expired - Lifetime
- 2002-10-30 UA UA20040504092A patent/UA79440C2/ru unknown
- 2002-10-30 CA CA2465667A patent/CA2465667C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4401170B2 (ja) | 2010-01-20 |
| US7928063B2 (en) | 2011-04-19 |
| DE60218199T2 (de) | 2007-11-22 |
| UA79440C2 (ru) | 2007-06-25 |
| CA2465667C (en) | 2011-03-08 |
| ATE353917T1 (de) | 2007-03-15 |
| CA2465667A1 (en) | 2003-05-08 |
| PL350463A1 (en) | 2003-05-05 |
| HU229220B1 (hu) | 2013-09-30 |
| EA007841B1 (ru) | 2007-02-27 |
| ES2282494T3 (es) | 2007-10-16 |
| EP1442059A2 (en) | 2004-08-04 |
| DE60218199D1 (de) | 2007-03-29 |
| JP2005517633A (ja) | 2005-06-16 |
| PL195917B1 (pl) | 2007-11-30 |
| EP1442059B1 (en) | 2007-02-14 |
| WO2003037928A2 (en) | 2003-05-08 |
| WO2003037928A3 (en) | 2004-03-04 |
| SI1442059T1 (sl) | 2007-08-31 |
| AU2002351536A1 (en) | 2003-05-12 |
| HUP0401589A2 (hu) | 2004-11-29 |
| US20060172927A1 (en) | 2006-08-03 |
| HUP0401589A3 (en) | 2005-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2957399T3 (es) | Método de síntesis de péptidos | |
| FI120691B (fi) | Ei-terapeuttinen menetelmä kasvuhormonin vapautumisen edistämiseksi eläimessä | |
| AU646767B2 (en) | Antithrombotic agents | |
| KR101904808B1 (ko) | 데가렐릭스 및 이의 중간 화합물의 제조 방법 | |
| HUT75708A (en) | Neurokinine (tachykinine) antagonists | |
| KR910006324A (ko) | 펩티다아제 및 아이소머라제 억제제 | |
| US8492345B2 (en) | Cyclic peptide antitumor agents | |
| EP0042291B1 (en) | Methods and compositions for preparation of h-arg-x-z-y-tyr-r | |
| AU673431B2 (en) | Motilin-like polypeptides that inhibit gastrointestinal motor activity | |
| EP0082568B1 (en) | Retro-inverso analogues of c-terminal penta and hexapeptides of substance p. | |
| EA200400603A1 (ru) | Новые пептиды - аналоги гормона высвобождения гормона роста человека | |
| HU185321B (en) | Process for preparing pharmacologically active ancephaline analogues | |
| JP2949129B2 (ja) | 胃腸運動刺激活性を有するモチリン類似ポリペプチド | |
| JPH08505611A (ja) | ５位及び６位に修飾アミノアシル残基を有するｌｈｒｈ拮抗薬 | |
| HU186375B (en) | Process for the preparation of biologically active encephalina derivatives | |
| HU185230B (en) | Process for producing pharmacologically active encephaline analogous peptides | |
| AU718320B2 (en) | Peptide derivatives | |
| RU2006106721A (ru) | Получение пептидов соматостатина | |
| AU718192B2 (en) | Peptide derivatives | |
| CA2118253A1 (en) | Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds | |
| CA1284550C (en) | Retro-inverso analogs of the bradykinin potentiating peptide bpp*in5a*xx | |
| GB992957A (en) | New decapeptides and their manufacture | |
| KR100445961B1 (ko) | α-(N,N-디알킬)-아미노카르복실산아미드의제조방법 | |
| JPH06509571A (ja) | タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物 | |
| US6218364B1 (en) | Fluorinated neurokinin A antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NF4A | Restoration of lapsed right to a eurasian patent | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM BY KZ MD TJ RU |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |